Engene Therapeutics Inc

1 institutions still hold Engene Therapeutics Inc as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 29286X101·1 13F holders·last filed Mar 31, 2026

Market cap

—

▲ 4.2%

vs prior quarter

13F value held

$191

75.0% inst. owned

of float

Holders

-138 QoQ

filers reporting

Activity

+11 / −69

+893 added · −775 reduced

this quarter

Concentration

100.00%

SBI Securities Co., Ltd. #1

top holder share

AI Holders Summary · Q1 2026

1 institutions reported ENGN in Q1 2026. SBI Securities Co., Ltd. leads at 100.0% of the visible book. -138 net institutions QoQ — distribution reading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter

SBI Securities Co., Ltd.

CIK 0001851815

$191280.00%Q1 2026